Globus Medical Buy Hold or Sell Recommendation

GMED -- USA Stock  

Quarterly Earning Report: November 14, 2019  

Given the investment horizon of 30 days, and your above average risk tolerance our recommendation regarding Globus Medical is 'Strong Buy'. Macroaxis provides Globus Medical buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding GMED positions. The advice algorithm takes into account all of Globus Medical available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from GMED buy-and-hold prospective. Please also check Globus Medical Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool.

Time Horizon

Risk Tolerance

Symbol
Execute Advice
Sell Globus MedicalBuy Globus Medical
Strong Buy

Volatility

Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Piotroski F Score

Financial Leverage

Inapplicable
For the selected time horizon Globus Medical has a risk adjusted performance of 0.1822, jensen alpha of 0.3201, total risk alpha of 0.3428, sortino ratio of 0.2486 and treynor ratio of 0.4545
Macroaxis buy or sell recommendations tool can be used to complement Globus Medical buy, hold, or sell suggestion provided by experts. It analyzes the entity potential to grow against your specific risk preferences and investment horizon. To make sure Globus Medical is not overpriced, please check out all Globus Medical fundamentals including its Price to Earning, Net Income, Book Value Per Share, as well as the relationship between Revenue and Total Debt . Given that Globus Medical has Number of Shares Shorted of 2.23 M, we strongly advise you confirm Globus Medical market performance and probability of bankruptcy to make sure the company can sustain itself in the current economic cycle given your regular risk tolerance and investing horizon.

Globus Medical Trading Alerts and Improvement Suggestions

Over 92.0% of the company shares are owned by institutional investors
Latest headline from MacroaxisInsider: Globus Medical exotic insider transaction detected

Globus Medical current analysts recommendations

Target Median Price55.00
Target Mean Price54.55
Recommendation Mean2.40
Target High Price62.00
Number Of Analyst Opinions11
Target Low Price45.00

Globus Medical Returns Distribution Density

Mean Return0.32Value At Risk1.82
Potential Upside2.93Standard Deviation1.73
 Return Density 
      Distribution 

Institutional Investors

Security TypeSharesValue
Gofen Glossberg LlcCommon Shares69.6 K3.6 M
Pacer Advisors IncCommon Shares28.1 K1.4 M
State Of Alaska Department Of RevenueCommon Shares13.6 K696 K
Crossmark Global Holdings IncCommon Shares12.5 K638 K
Carroll Financial Associates IncCommon Shares38.01000
Blackrock IncCommon Shares9.6 M407.3 M
Vanguard Group IncCommon Shares7.2 M303.8 M

Globus Medical Greeks

α
Alpha over DOW
=0.32
β
Beta against DOW=0.67
σ
Overall volatility
=1.75
Ir
Information ratio =0.19

Globus Medical Volatility Alert

Globus Medical has relatively low volatility with skewness of 1.38 and kurtosis of 4.64. However, we advise all investors to independently investigate Globus Medical to ensure market all accessible information is consistent with the expectations about its upside potential and future risk-adjusted return.
    
 Better Than Average     
    
 Worse Than Average Compare Globus Medical to competition

Globus Medical Fundamental Vs Peers

FundamentalsGlobus MedicalPeer Average
Return On Equity0.18 (0.31) 
Return On Asset0.16 (0.14) 
Profit Margin0.23 (1.27) 
Operating Margin29.12 (5.51) 
Current Valuation4.9 B16.62 B
Shares Outstanding76.65 M571.82 M
Shares Owned by Insiders3.57 10.09 
Shares Owned by Institutions92.44 39.21 
Number of Shares Shorted2.23 M4.71 M
Price to Earning37.03 28.72 
Price to Book3.99 9.51 
Price to Sales6.92 11.42 
Revenue742.66 M9.43 B
Gross Profit553.56 M27.38 B
EBITDA216.23 M3.9 B
Net Income143.33 M570.98 M
Cash and Equivalents240.43 M2.7 B
Cash per Share2.43 5.01 
Total Debt1.98 M5.32 B
Debt to Equity0.10 48.70 
Current Ratio6.94 2.16 
Book Value Per Share5.38 1.93 K
Cash Flow from Operations32.12 M971.22 M
Short Ratio5.29 4.00 
Earnings Per Share1.40 3.12 
Price to Earnings To Growth2.74 4.89 
Number of Employees1.8 K18.84 K
Beta0.91-0.15
Market Capitalization5.14 B19.03 B
Total Asset834.1 M29.47 B
Retained Earnings337.94 M9.33 B
Working Capital462.11 M1.48 B
Current Asset544.8 M9.34 B
   Acquisition by Murphy A Brett of 25000 shares of Globus Medical subject to Rule 16b-3 [view details]

Globus Medical Market Momentum

Search macroaxis.com